NovoCure Ltd. (NVCR) PT Raised to $28 at Mizuho Securities Citing Potential for CMS Reimbursement Approval
Mizuho Securities raised its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
